Paula J. Fonseca

TTD expert consensus on emesis in gastric cancer: evidence-based strategies for prevention and treatment.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 26, 2025

Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding.

Journal: Haematologica

Published: July 01, 2024

SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 18, 2023

SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 14, 2016

A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia.

Journal: British journal of cancer

Published: January 22, 2016

Living with Cancer: Through the Eyes of the Patient and the Physician.

Journal: Oncology and therapy

Published: January 01, 2016

Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution.

Journal: The Journal of community and supportive oncology

Published: June 30, 2014

Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.

Journal: Expert review of anticancer therapy

Published: June 24, 2014

Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 16, 2013

TTD expert consensus on emesis in gastric cancer: evidence-based strategies for prevention and treatment.

TTD expert consensus on emesis in gastric cancer: evidence-based strategies for prevention and treatment.

Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding.

Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding.

SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).

SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).

SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016).

SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016).

A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia.

A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia.

Living with Cancer: Through the Eyes of the Patient and the Physician.

Living with Cancer: Through the Eyes of the Patient and the Physician.

Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution.

Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution.

Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.

Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.

Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.

Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.

Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma.

Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma.

Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors.

Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors.

Prognostic factors in patients with advanced renal cell carcinoma.

Prognostic factors in patients with advanced renal cell carcinoma.